Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Apr 27;25(2):166–172. doi: 10.1111/j.1365-2222.1995.tb01022.x

Nasal cytokines in common cold and allergic rhinitis

M LINDEN 1,2,, L GREIFF 3, M ANDERSSON 3, C SVENSSON 3, A ÅKERLUND 3, M BENDE 4, E ANDERSSON 2, C G A PERSSON 1,5
PMCID: PMC7164831  PMID: 7750009

Summary

Coronavirus‐induced common cold and allergen‐induced rhinitis are characterized by nasal mucosal exudation of bulk blood plasma. The mucosal exudation process involves ‘flooding’ of the lamina propria with plasma‐derived binding proteins and it is possible that subepithelial inflammatory cytokines and mediators may be moved by the exudate to the mucosal surface. In this study, we have analysed cytokine levels in nasal lavage (NAL) fluids from non‐allergic subjects inoculated with coronavirus (n= 20) and from subjects with allergic (birch pollen) rhinitis subjected to additional allergen challenge (samples were obtained 35min post challenge) in the laboratory (n= 10). Ten of the 20 inoculated subjects developed common cold and 10 remained healthy. Interferon‐γ (IFN‐γ), interleukin‐1β (IL‐1β), granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), IL‐4, and IL‐6 were analysed in unprocessed NAL fluids using immunoassays. The subjects who developed common cold had increased NAL fluid levels of IFNγ (P < 0.05) that correlated well with the symptoms (P < 0.001). IFNγ did not increase in subjects with allergic rhinitis. IL‐1β levels were similar in NAL fluids obtained from all inoculated subjects. In the subjects with allergic rhinitis NAL fluid levels of both IL‐1β and GM‐CSF were increased (P < 0.05). GM‐CSF was not detected in common cold. IL‐4 and IL‐6 were not detectable in any of the NAL fluids. The present cytokines may not only emanate from superficial mucosal cells. By aiding plasma exudation subepithelial cytokines may potentially also be retrieved on the mucosal surface. Our study provides original in vivo data supporting the notion that a TH‐1 profile of cytokines, notably IFNγ, is present in viral infection and further supporting the view that GM‐CSF is an important cytokine in allergic airways disease.

Supported by the Swedish Medical Research Council (project 8308), the Medical Faculty of Lund University, the Swedish Association against Asthma and Allergy, Astra Draco, and Janssen Pharma, Sweden.

References

  • 1. Akerlund A, Greiff L, Andersson M et al. Mucosal exudation of fibrinogen in corona virus‐induced common colds. Acta Otolaryngol (Stockh) 1993; 113:642–8. [DOI] [PubMed] [Google Scholar]
  • 2. Svensson C, Klementsson H, Andersson M et al. Glucocorticoid‐induced attenuation of mucosal exudation of fibrinogen and bradychinins in seasonal allergic rhinitis. Allergy, in press. [DOI] [PubMed] [Google Scholar]
  • 3. Bonner JC, Brody AR. Cytokine‐binding proteins In: Kelly J, ed. Cytokines of the lung. New York : Decker; 1992: 459–89. [Google Scholar]
  • 4. Persson CGA, Svensson C, Greiff L et al. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992; 47:993–1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Persson CGA. Airway epithelium and microcirculation. Eur Respir Rev, in press. [Google Scholar]
  • 6. Dinarello CA. Biology of interleukin‐1. FASEB J 1988; 2:108–15. [PubMed] [Google Scholar]
  • 7. Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56:234–48. [PubMed] [Google Scholar]
  • 8. Kishimoto T. The biology of interleukin‐6. Blood 1989; 74:1–10. [PubMed] [Google Scholar]
  • 9. Tranchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6:131–6. [DOI] [PubMed] [Google Scholar]
  • 10. Metcalf D, Flegley CG, Nicola NA et al. Biologic properties in vitro of the recombinant human granulocyte‐macrophage colony‐stimulating factor. Blood 1986; 67:37–45. [PubMed] [Google Scholar]
  • 11. Prete Del GF, Maggi E, Parronchi I et al. IL‐4 is an essential factor for IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140:4193–8. [PubMed] [Google Scholar]
  • 12. Holt PG, McMenamion C, Nelson D. Primary sensitisation to inhalant allergens during infancy. Ped Allergy Immunol 1990; 1:3–12. [Google Scholar]
  • 13. Zang ZY, Michael JG. Orally inducible immune un‐responsiveness is abrogated by IFN‐7 treatment. J Immunol 1990; 144:4163–5. [PubMed] [Google Scholar]
  • 14. Cypcar D, Stark J, Lemanske RF. The impact of respiratory infections in asthma. Pediatr Clin North Am 1992; 39:1259–76. [DOI] [PubMed] [Google Scholar]
  • 15. Persson CGA, Greiff L, Akerlund A et al. The mucosal inflammatory process is nocturnal in coronavirus‐induced common cold. Am Rev Respir Dis 1993; 147:A66. [Google Scholar]
  • 16. Svensson C, Andersson M, Gronneberg R et al. Allergen challenge‐induced exudation of alpha2‐macroglobulin across nasal and bronchial mucosa. Allergy 1993; 48(suppl):91. [Google Scholar]
  • 17. Beare A, Reed S. The study of anti‐viral compounds in volunteers In: Oxford JS, ed. Chemoprophylaxis and virus infections of the respiratory tract (vol 2). Cleveland : CRC Press; 1977:28–55. [Google Scholar]
  • 18. Greiff L, Pipkorn U, Alkner U, Persson CGA. The ‘nasal pool’ device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990; 20:253–9. [DOI] [PubMed] [Google Scholar]
  • 19. Andersson G, Ekre HPT, Alm G, Perlmann P. Monoclonal antibody two‐site ELISA for human IFN‐7. Adaptation for determinations in human serum or plasma. J Immunol Meth 1989; 125:89–96. [DOI] [PubMed] [Google Scholar]
  • 20. Gustafsson B, Persson CGA. Asymetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. Clin Exp Allergy 1991; 21:121–6. [DOI] [PubMed] [Google Scholar]
  • 21. Greiff L, Wollmer P, Pipkorn U, Persson CGA. Absorption of 51‐CrEDTA across the human nasal mucosa in the presence of topical histamine. Thorax 1991; 46:630–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Erjefält I, Persson CGA. Allergen, bradykinin, and cap‐saicin increase outward but not inward macromolecular permeability of guinea‐pig tracheobronchial mucosa, Clin Exp Allergy 1991; 21:217–24. [DOI] [PubMed] [Google Scholar]
  • 23. Romagnani S. Induction of Th1 and Th2 responses: a key role for the ‘natural’ immune response Immunol Today 1992; 13:379–81. [DOI] [PubMed] [Google Scholar]
  • 24. Ricci M, Rossi O. Dysregulation of IgE responses and airway inflammation in atopic individuals. Clin Exp Allergy 1990; 20:601–10. [DOI] [PubMed] [Google Scholar]
  • 25. Hsia J, Goldstein AL, Simon GL, Sztein M, Hayden FG. Peripheral blood mononuclear cell interleukin‐2 and interferon‐γ production, cytotoxicity and antigen‐stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 1990; 162:591–7. [DOI] [PubMed] [Google Scholar]
  • 26. Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster IL‐3, IL‐4, IL‐5 and GM‐CSF in allergen‐induced late phase cutaneous reaction in atopic subjects. J Exp Med 1991; 173:775–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL‐3, IL‐4, IL‐5, and granulocyte‐macrophage colony‐stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390–4. [PubMed] [Google Scholar]
  • 28. Robinson DS, Hamid Q, Ying Sun et al. Predominant TH2‐like bronchoalveolar T‐lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298–304. [DOI] [PubMed] [Google Scholar]
  • 29. Walker CE, Bode L, Boer TT, Hansel K, Blaser K., Virehow JC. Allergic and non‐allergic asthmatics have distinct patterns of T‐cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146:109–15. [DOI] [PubMed] [Google Scholar]
  • 30. Dayton MA, Knobloch TJ, Benjamin D. Human B cell lines express the interferon gamma gene. Cytokine 1992; 4:454–60. [DOI] [PubMed] [Google Scholar]
  • 31. Pipkorn U, Karlsson G, Enerback L. The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol 1988; 82:1046–54. [DOI] [PubMed] [Google Scholar]
  • 32. Varney VA, Jacobson MR, Sudderick RM et al. Immuno‐histology of the nasal mucosa following allergen‐induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992; 146:170–6. [DOI] [PubMed] [Google Scholar]
  • 33. Fraenkel DJ, Bradin PG, Johnston SL et al. Nasal biopsies in human rhinovirus infection: an immunohistochemical study. Am Rev Respir Dis 1993; 147:A460. [Google Scholar]
  • 34. GreifF L, Andersson M, Akerlund A et al. Microvascular exudative hyperresponsiveness in human corona virus‐induced common cold. Thorax 1994; 49:121–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Higgins PG, AI‐Nakib W, Barrow GI, Tyrrell DAJ. Recombinant human interferon‐7 as prophylaxes against rhino‐virus colds in volunteers. J Interferon Res 1988; 8:591–6. [DOI] [PubMed] [Google Scholar]
  • 36. Wagner CD, Gundel RH, Reilly P et al. Intracellular adhesion molecule‐1 (ICAM‐1) in the pathogenesis of asthma. Science 1990; 247:456–9. [DOI] [PubMed] [Google Scholar]
  • 37. Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM‐1. Cell 1989; 56:839–47. [DOI] [PubMed] [Google Scholar]
  • 38. Ida S, Hooks J, Siraganian RP, Notkins AL. Enhancement of IgE‐mediated histamine release from human basophils by viruses. Role of interferon. J Exp Med 1977; 145:892–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Ida S, Hooks J, Siraganian RP, Notkins AL. Enhancement of IgE‐mediated histamine release from human basophils by immune‐specific lymphokines. Clin Exp Immunol 1980; 41:380–7. [PMC free article] [PubMed] [Google Scholar]
  • 40. Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989:83:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Huftel MA, Swensen CA, Borcherding WR et al. The effect of T‐cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus. Am J Respir Cell Mol Biol 1992; 7:434–40. [DOI] [PubMed] [Google Scholar]
  • 42. Valerius T, Repp R, Kalden JR, Platzen E. Effects of IFN on human eosinophils in comparison with other cytokincs. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990; 145:2950–8. [PubMed] [Google Scholar]
  • 43. Busse WW, Lemanske RF, Dick EC. The relationship of viral respiratory infections and asthma. Chest 1992; 101(suppl):385S–388S. [DOI] [PubMed] [Google Scholar]
  • 44. Bardin PG, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin Exp Allergy 1992; 22:809–22. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Allergy are provided here courtesy of Wiley

RESOURCES